CN105567618B - Hsv1-h129-bac及其变体的构建方法与应用 - Google Patents
Hsv1-h129-bac及其变体的构建方法与应用 Download PDFInfo
- Publication number
- CN105567618B CN105567618B CN201511029238.8A CN201511029238A CN105567618B CN 105567618 B CN105567618 B CN 105567618B CN 201511029238 A CN201511029238 A CN 201511029238A CN 105567618 B CN105567618 B CN 105567618B
- Authority
- CN
- China
- Prior art keywords
- bac
- virus
- gfp
- seq
- sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/65—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression using markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/66—General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
- C12Q1/06—Quantitative determination
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/18—Testing for antimicrobial activity of a material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16631—Uses of virus other than therapeutic or vaccine, e.g. disinfectant
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16641—Use of virus, viral particle or viral elements as a vector
- C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16651—Methods of production or purification of viral material
- C12N2710/16652—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/106—Plasmid DNA for vertebrates
- C12N2800/107—Plasmid DNA for vertebrates for mammalian
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Toxicology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Virology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
2hpi | 6hpi | 12hpi | 24hpi | 48hpi | 72hpi | |
H129-WT(-GCV) | 5.4×10 | 7×10<sup>2</sup> | 1×10<sup>4</sup> | 9×10<sup>4</sup> | 9×10<sup>5</sup> | 2×10<sup>7</sup> |
H129-WT(﹢GCV) | 5×10 | 5.8×10 | 6×10 | 6.6×10 | 7.3×10 | 8.3×10 |
2hpi | 6hpi | 12hpi | 24hpi | 48hpi | 72hpi | |
H129-BA(-GCV) | 4.5×10 | 5×10<sup>2</sup> | 6.5×10<sup>3</sup> | 2.3×10<sup>4</sup> | 4.5×10<sup>5</sup> | 4.5×10<sup>6</sup> |
H129-BA(﹢GCV) | 1×10 | 3×10 | 3.9×10 | 6.5×10 | 6.5×10 | 8×10 |
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511029238.8A CN105567618B (zh) | 2015-12-31 | 2015-12-31 | Hsv1-h129-bac及其变体的构建方法与应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201511029238.8A CN105567618B (zh) | 2015-12-31 | 2015-12-31 | Hsv1-h129-bac及其变体的构建方法与应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105567618A CN105567618A (zh) | 2016-05-11 |
CN105567618B true CN105567618B (zh) | 2020-12-08 |
Family
ID=55878252
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201511029238.8A Active CN105567618B (zh) | 2015-12-31 | 2015-12-31 | Hsv1-h129-bac及其变体的构建方法与应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105567618B (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107630009A (zh) * | 2016-07-19 | 2018-01-26 | 中国科学院武汉物理与数学研究所 | 一种减毒增亮、复制可控的hsv重组病毒及制备方法和应用 |
CN106544326B (zh) * | 2016-11-07 | 2020-06-26 | 中国科学院武汉病毒研究所 | 顺行跨多级突触、跨神经元的示踪系统 |
CN106520709A (zh) * | 2016-11-07 | 2017-03-22 | 中国科学院武汉病毒研究所 | 顺行跨单级突触神经示踪系统 |
WO2018082093A1 (en) * | 2016-11-07 | 2018-05-11 | Wuhan Institute Of Virology, Chinese Academy Of Sciences | Anterograde monosynaptic transneuronal tracer system |
CN110029127A (zh) * | 2018-01-11 | 2019-07-19 | 中国科学院武汉物理与数学研究所 | 一种携带荧光Timer基因可变色的重组单纯疱疹病毒及制备方法和应用 |
CN112501137B (zh) * | 2020-11-11 | 2023-10-20 | 深圳先进技术研究院 | 一种神经环路标记系统 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009051823A2 (en) * | 2007-10-18 | 2009-04-23 | Michigan State University | Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof |
CN101864442A (zh) * | 2010-05-19 | 2010-10-20 | 江苏省农业科学院 | 重组火鸡疱疹病毒细菌人工染色体转移载体 |
-
2015
- 2015-12-31 CN CN201511029238.8A patent/CN105567618B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009051823A2 (en) * | 2007-10-18 | 2009-04-23 | Michigan State University | Bacterial artificial chromosome containing feline herpes virus type 1 genome and uses thereof |
CN101864442A (zh) * | 2010-05-19 | 2010-10-20 | 江苏省农业科学院 | 重组火鸡疱疹病毒细菌人工染色体转移载体 |
Non-Patent Citations (4)
Title |
---|
Construction and characterization of bacterial artificial chromosomes containing HSV-1 strains 17 and KOS;GIERASCH,W.W.等;《JORURNAL OF VIROLOGICAL METHODS》;20060502;第135卷;197-206 * |
Construction of an Excisable Bacterial Artificial Chromosome Containing a Full-Length Infectious Clone of Herpes Simplex Virus Type 1: Viruses Reconstituted from the Clone Exhibit Wild-Type Properties In Vitro and In Vivo;Michiko T.等;《JOURNAL OF VIROLOGY》;20030131;第77卷(第2期);1382-1391 * |
Evaluation of HSV-1 and adenovirus vector-mediated infection,replication and cytotoxicity in lymphoma cell lines;ZHANG,X.D.等;《ONCOLOGY REPORTS》;20111231;第26卷;637-644 * |
The Complete DNA Sequence of the Long Unique Region in the Genome of Herpes Simplex Virus Type I;McGEOCH,D.J.等;《J.GEN.VIROL.》;19881231;第69卷;1531-1574 * |
Also Published As
Publication number | Publication date |
---|---|
CN105567618A (zh) | 2016-05-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105567618B (zh) | Hsv1-h129-bac及其变体的构建方法与应用 | |
Wille et al. | A human cytomegalovirus gO-null mutant fails to incorporate gH/gL into the virion envelope and is unable to enter fibroblasts and epithelial and endothelial cells | |
Hahn et al. | The human cytomegalovirus ribonucleotide reductase homolog UL45 is dispensable for growth in endothelial cells, as determined by a BAC-cloned clinical isolate of human cytomegalovirus with preserved wild-type characteristics | |
Ma et al. | A new model of Epstein-Barr virus infection reveals an important role for early lytic viral protein expression in the development of lymphomas | |
Liu et al. | A duck enteritis virus-vectored bivalent live vaccine provides fast and complete protection against H5N1 avian influenza virus infection in ducks | |
Tischer et al. | A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9 | |
Banerjee et al. | Therapeutic gene delivery in human B-lymphoblastoid cells by engineered non-transforming infectious Epstein–Barr virus | |
Moore et al. | The African swine fever virus thymidine kinase gene is required for efficient replication in swine macrophages and for virulence in swine | |
Robertson et al. | An Epstein-Barr virus with a 58-kilobase-pair deletion that includes BARF0 transforms B lymphocytes in vitro | |
Zhang et al. | Marek's disease virus-encoded MicroRNA 155 ortholog critical for the induction of lymphomas is not essential for the proliferation of transformed cell lines | |
WO2022218325A1 (zh) | 一种基因缺失的减毒非洲猪瘟病毒毒株及其构建方法和应用 | |
WO2020239040A1 (zh) | 重组溶瘤病毒以及制备方法、应用和药物 | |
Tandon et al. | Control of cytoplasmic maturation events by cytomegalovirus tegument protein pp150 | |
CN102212559B (zh) | 一种重组的hsv扩增子载体及其用途 | |
Pagnani et al. | Molecular and biological properties of BK virus-IR, a BK virus variant isolated from a human tumor | |
CN108220251B (zh) | 一种重组传染性脓疱溶瘤病毒及其制备方法与应用 | |
Takimoto et al. | Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells | |
Lilja et al. | Functional genetic analysis of rhesus cytomegalovirus: Rh01 is an epithelial cell tropism factor | |
CN105713866B (zh) | 人巨细胞病毒感染性克隆及其构建方法和应用 | |
CN104928261A (zh) | 伪狂犬病病毒la-a株、构建方法及其应用 | |
Chen et al. | Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain | |
EP2460878B1 (en) | Orf7 deficient varicella virus, vaccine comprising the virus and use thereof | |
EP3992282A1 (en) | Method for producing virus and harvest liquid composition | |
He et al. | Rana grylio virus as a vector for foreign gene expression in fish cells | |
Bilello et al. | A genetic system for rhesus monkey rhadinovirus: use of recombinant virus to quantitate antibody-mediated neutralization |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Luo Minhua Inventor after: Zeng Wenbo Inventor after: Jiang Haifei Inventor after: Zhao Fei Inventor after: Chen Zhangzhou Inventor before: Luo Minhua Inventor before: Zeng Wenbo Inventor before: Jiang Haifei Inventor before: Zhao Fei Inventor before: Chen Zhangzhou Inventor before: Xu Fuqiang |
|
COR | Change of bibliographic data | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 430071 No. 44, Middle District, little Hongshan, Wuchang District, Hubei, Wuhan Applicant after: Wuhan Institute of Virology, Chinese Academy of Sciences Address before: 430071 No. 44, Middle District, little Hongshan, Hongshan District, Hubei, Wuhan Applicant before: Wuhan Institute of Virology, Chinese Academy of Sciences |
|
GR01 | Patent grant | ||
GR01 | Patent grant |